Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Gut dysbiosis in SARS-CoV-2 infected monkeys
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Gut dysbiosis in SARS-CoV-2 infected monkeys
Gastroenterology

Gut dysbiosis in SARS-CoV-2 infected monkeys

Covid-19
Pulmonology Gastroenterology

A French team from the Lille Center for Infection and Immunity, in collaboration with CEA, INRAE, the Pasteur Institute and the Saint-Antoine Hospital in Paris, has shown that SARS-CoV-2, the virus that causes Covid-19, provokes a gut dysbiosis in monkeys which persists even after the virus has been eliminated.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
Actu PRO : Dysbiose intestinale chez les macaques infectés par le SARS-CoV-2

About this article

Created 08 June 2021
Updated 13 August 2024

The tightly regulated interplay between gut microbiota and host influences many physiological functions including immune homeostasis. A body of preclinical and clinical evidence shows that gut microbiota composition is transiently altered in the context of acute viral respiratory infections. In the case of Covid-19, studying the gut microbiota during infection is particularly important, given that SARS-CoV-2 can bind to ACE2 receptors in the gut, the virus is found in the intestine in up to 25% of patients, and the gut microbiota alterations associated with pulmonary and intestinal complications are likely to influence disease severity. This preclinical study is the first to investigate the role of SARS-CoV-2 infection in dynamic changes in the gut microbiota of monkeys.

The monkey: a good model for SARS-CoV-2 infection

The human data currently available on Covid-19 are abundant but do not allow the disease to be followed throughout its course, from pre-infection to post-resolution. The researchers used two species of monkeys (cynomolgus monkey and rhesus monkey) to fill in certain missing pieces of the infection puzzle. These non-human primates are a suitable model for the study of Covid-19, since SARS-CoV-2 infection led to virus replication in their upper and lower respiratory tracts, resulting in lung pathology and respiratory disease with no overt clinical symptoms. Two monkeys from each species were infected intranasally and intratracheally. Blood (to measure cytokine levels) and stool samples were collected 9 days prior to infection and at 0, 3, 5, 7, 10, 13, 20, and 26 days post-infection (dpi). Two of the monkeys had transient diarrhea at 4 dpi.

Covid-19: persistent dysbiosis even after resolution...

16S rRNA gene sequencing revealed significant changes in the composition of the monkeys’ gut microbiota, with a peak at 10-13 dpi. Some alterations in the microbiota persisted after SARS-CoV-2 was eliminated from the upper respiratory tract (virus undetectable in the nasopharynx and trachea at 20 dpi, but still detectable in the stool of two monkeys) and even at 26 dpi. A significant number of changes in the abundance of bacterial taxa were observed during infection, particularly at 13 dpi. In particular, the relative abundance of Acinetobacter and some genera of the Ruminococcaceae family was positively correlated with the presence of SARS-CoV-2 in the upper respiratory tract.

...and a gut microbiota with altered functional activity

A metabolomic approach was used to evaluate the functional consequences of the changes in the gut microbiota associated with the infection. The aim here was to quantify three of the most important categories of microbiota-derived metabolites: short-chain fatty acids (SCFAs), bile acids, and tryptophan metabolites. SCFA levels changed over the course of the infection, particularly between 2 and 13 dpi. Changes in several bile acids and tryptophan metabolites were also identified in infected animals. The relative abundance of several taxa known to be SCFA producers (mostly from the Ruminococcaceae family) was negatively correlated with certain systemic inflammatory markers, while the genus Streptococcus was strongly and positively correlated with the same markers. This study shows that experimental infection with SARS-CoV-2 in monkeys is associated with a disruption of the gut microbiota’s composition and functional activity. The persistence of dysbiosis after resolution of the infection may play a role in the long Covid-19 symptoms currently being reported in humans.

Sources

Sokol H, Contreras V, Maisonnasse P, et al. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes. 2021;13(1):1-19.

Tags
Immunity Dysbiosis Covid-19 Virus SARS-CoV-2 Monkey Microbiome Flora
    Created 08 June 2021
    Updated 13 August 2024

    About this article

    To know more about this topic.

    Main topic

    Covid-19

    Medical practice

    Pulmonology Gastroenterology

    Content type

    News
    Gastroenterology

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irrita...

    Find out more

    Probiotics: what exactly are we talking about?

    From the Latin pro and Greek bios meaning “for life”, the term “probiotic” was suggested over 60 year...

    Find out more

    How do you choose a probiotic for your patient?

    Faced with a plethora of products on the market, it's not always easy for health professionals to sug...

    Find out more

    The Janus face of Antibiotics: Life Savers and Microbiota Disruptors

    A page turns: with the advent of antibiotics in the...

    Find out more

    Fecal transplantation - ready for prime time?

    Congress review By Pr. Danny De Looze Department of Gastroenterology University Hospital Gent, Belgi...

    Find out more

    Focus on antibiotic associated diarrhea (AAD)

    Find out more

    Dampening gastrointestinal inflammation through nutrition

    by Dr Genelle Healey

    Find out more

    Continue reading

    News
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    07.02.2025

    Your functional dyspepsia diagnosis check list

    Read the article
    17.04.2025

    Sensitivity to the additive E466: the role of the microbiota

    Read the article
    Photo HCPs: Clinical context over quick fix: the fresh consensus on microbiome testing
    11.04.2025

    Clinical context over quick fix: the fresh consensus on microbiome testing

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    Actu PRO : Alcoolisme : expliquer les troubles sociaux grâce au microbiote
    27.01.2021

    Alcoholism: explaining social disorders thanks to the microbiota

    Read the article
    20.03.2025

    Entacapone and the gut: a hidden impact on parkinson’s care

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo